T

Trevena, Inc.

43 employees

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

Basic info

biotechnology research

Biotechnology

Pharmaceutical

drug discovery & development

acute care medicine

Biopharma

GPCRs

pain medicine

CNS Disorders

Health Care

2008

$60M

from 3 investors over 3 rounds

T

Trevena, Inc. raised $35M on September 22, 2014

Investors: Oxford Finance LLC and Square 1 Bank

T

Trevena, Inc. raised $60M on May 9, 2013

Investors: Forest Laboratories